These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 22632387)
1. Medium-term culture of primary oral squamous cell carcinoma in a three- dimensional model: effects on cell survival following topical 5-fluororacile delivery by drug-loaded matrix tablets. Campisi G; Giannola LI; Fucarino A; Marino Gammazza A; Pitruzzella A; Marciano V; De Caro V; Siragusa MG; Giandalia G; Compilato D; Holgate ST; Davies DE; Farina F; Zummo G; Paderni C; Bucchieri F Curr Pharm Des; 2012; 18(34):5411-20. PubMed ID: 22632387 [TBL] [Abstract][Full Text] [Related]
2. 5-Fluorouracil buccal tablets for locoregional chemotherapy of oral squamous cell carcinoma: formulation, drug release and histological effects on reconstituted human oral epithelium and porcine buccal mucosa. Giannola LI; De Caro V; Giandalia G; Siragusa MG; Paderni C; Campisi G; Florena AM Curr Drug Deliv; 2010 Apr; 7(2):109-17. PubMed ID: 20158481 [TBL] [Abstract][Full Text] [Related]
3. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma. Srivastava S; Gupta S; Mohammad S; Ahmad I J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells. Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776 [TBL] [Abstract][Full Text] [Related]
5. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma. Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells. Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181 [TBL] [Abstract][Full Text] [Related]
7. Ethogel topical formulation for increasing the local bioavailability of 5-fluorouracil: a mechanistic study. Puri R; Jain S Anticancer Drugs; 2012 Oct; 23(9):923-34. PubMed ID: 22926258 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. Li S; Wang A; Jiang W; Guan Z BMC Cancer; 2008 Apr; 8():103. PubMed ID: 18412945 [TBL] [Abstract][Full Text] [Related]
9. Self-Assembling Monomeric Nucleoside Molecular Nanoparticles Loaded with 5-FU Enhancing Therapeutic Efficacy against Oral Cancer. Zhao H; Feng H; Liu D; Liu J; Ji N; Chen F; Luo X; Zhou Y; Dan H; Zeng X; Li J; Sun C; Meng J; Ju X; Zhou M; Yang H; Li L; Liang X; Chu L; Jiang L; He Y; Chen Q ACS Nano; 2015 Oct; 9(10):9638-51. PubMed ID: 26349079 [TBL] [Abstract][Full Text] [Related]
10. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes. Harada K; Ferdous T; Ueyama Y Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells. Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447 [TBL] [Abstract][Full Text] [Related]
12. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma. Yang M; Luo Q; Chen X; Chen F J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines. Okamura M; Shimada J; Sakagami H Anticancer Res; 2008; 28(1A):253-9. PubMed ID: 18383853 [TBL] [Abstract][Full Text] [Related]
14. Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells. Suzuki M; Shinohara F; Endo M; Sugazaki M; Echigo S; Rikiishi H Cancer Chemother Pharmacol; 2009 Jul; 64(2):223-32. PubMed ID: 18830594 [TBL] [Abstract][Full Text] [Related]
15. ZIF-8 as a pH-Responsive Nanoplatform for 5-Fluorouracil Delivery in the Chemotherapy of Oral Squamous Cell Carcinoma. Hao J; Chen C; Pavelic K; Ozer F Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273239 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. Suzuki M; Shinohara F; Nishimura K; Echigo S; Rikiishi H Int J Oncol; 2007 Dec; 31(6):1449-56. PubMed ID: 17982671 [TBL] [Abstract][Full Text] [Related]
17. Enhanced susceptibility of oral squamous cell carcinoma cell lines to FAS-mediated apoptosis by cisplatin and 5-fluorouracil. Iwase M; Watanabe H; Kondo G; Ohashi M; Nagumo M Int J Cancer; 2003 Sep; 106(4):619-625. PubMed ID: 12845662 [TBL] [Abstract][Full Text] [Related]
18. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma. Harada K; Ferdous T; Harada T; Ueyama Y Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058 [TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973 [TBL] [Abstract][Full Text] [Related]
20. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells. Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]